In Situ Hybridization: An Informative Technique for Pigment Cell Researchers

Pigment Cell Research

Volumn 17, Issue 1, 2004, Pages 10-14

  Suzuki, Itaru ^a,b   Motokawa, Tomonori ^a  

^a POLA CHEMICAL INDUSTRIES INC   (Japan)

^b NONE   (France)

Author keywords

Development; Differentiation; In situ hybridization; Melanocyte; Melanoma; Pigmentation

Indexed keywords

MESSENGER RNA; PROTEOME; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANIMAL TISSUE; CELL CULTURE; DNA MICROARRAY; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MELANOCYTE; MELANOMA; MESSENGER RNA PROFILING; NONHUMAN; PIGMENT CELL; PIGMENTATION; PROTEOMICS; RESEARCH; REVIEW; RNA ANALYSIS; RNA TRANSCRIPTION; TECHNIQUE; TISSUE; TISSUE IN SITU HYBRIDIZATION; TRANSCRIPTION REGULATION;

ANIMALS; DNA, COMPLEMENTARY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MELANOCYTES; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOME; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PROBES; RNA, MESSENGER; SKIN; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 0842348923     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-0749.2003.00112.x     Document Type: Review

References (34)

1. Loftus SK, Pavan WJ. The use of expression profiling to study pigment cell biology and dysfunction. Pigment Cell Res 2000;13:141-146
2. Dooley TP, Curto EV, Davis RL, Grammatico P, Robinson ES, Wilborn TW. DNA microarrays and likelihood ratio bioinformatic methods: discovery of human melanocyte biomarkers. Pigment Cell Res 2003;16:245-253
3. Valery C, Grob JJ, Verrando P. Identification by cDNA microarray technology of genes modulated by artificial ultraviolet radiation in normal human melanocytes: relation to melanocarcinogenesis. J Invest Dermatol 2001;117:1471-1482
4. Weeraratna AT. Serial analysis of gene expression (SAGE): advances, analysis and applications to pigment cell research. Pigment Cell Res 2003;16:183-189
5. Coleman RA, Clark KL. Target validation using human tissue: from gene expression to function. Targets 2003;2:58-64
6. Watanabe K, Takeda K, Yasumoto K, Udono T, Saito H, Ikeda K, Takasaka T, Takahashi K, Kobayashi T, Tachibana M, Shibahara S. Identification of a distal enhancer for the melanocyte-specific promoter of the MITF gene. Pigment Cell Res 2002;15:201-211
7. Zaidi AU, Enomoto H, Milbrandt J, Roth KA. Dual fluorescent in situ hybridization and immunohistochemical detection with tyramide signal amplification. J Histochem Cytochem 2000;48:1369-1375
8. Breininger JF, Baskin DG. Fluorescence in situ hybridization of scarce leptin receptor mRNA using the enzyme-labeled fluorescent substrate method and tyramide signal amplification. J Histochem Cytochem 2000;48:1593-1599
9. Ishii Y, Nakamura S, Osumi N. Demarcation of early mammalian cortical development by differential expression of fringe genes. Brain Res Dev Brain Res 2000;119:307-320
10. Skacel M, Skilton B, Pettay JD, Tubbs RR. Tissue microarrays: a powerful tool for high-throughput analysis of clinical specimens: a review of the method with validation data. Appl Immunohistochem Mol Morphol 2002;10:1-6
11. Bubendorf L, Nocito A, Moch H, Sauter G. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 2001;195:72-79
12. Bubendorf L. High-throughput microarray technologies: from genomics to clinics. Eur Urol 2001;40:231-238
13. Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 2001;10:657-662
14. Moch H, Kononen T, Kallioniemi OP, Sauter G. Tissue microarrays: what will they bring to molecular and anatomic pathology? Adv Anat Pathol 2001;8:14-20
15. Furumura M, Sakai C, Potterf SB, Vieira WD, Barsh GS, Hearing VJ. Characterization of genes modulated during pheomelanogenesis using differential display. Proc Natl Acad Sci USA 1998;95:7374-7378
16. LePoole IC, Sarangarajan R, Zhao Y, Stennett LS, Brown TL, Sheth P, Miki T, Boissy RE. 'VIT1', a novel gene associated with vitiligo. Pigment Cell Res 2001;14:475-484
17. Basrur V, Yang F, Kushimoto T, Higashimoto Y, Yasumoto K, Valencia J, Muller J, Vieira WD, Watabe H, Shabanowitz J, Hearing VJ, Hunt DF, Appella E. Proteomic analysis of early melanosomes: identification of novel melanosomal proteins. J Proteome Res 2003;2:69-79
18. Nanney LB, Coffey RJ Jr, Ellis DL. Expression and distribution of transforming growth factor-alpha within melanocytic lesions. J Invest Dermatol 1994;103:707-714
19. Scott G, Stoler M, Sarkar S, Halaban R. Localization of basic fibroblast growth factor mRNA in melanocytic lesions by in situ hybridization. J Invest Dermatol 1991;96:318-322
20. Reed JA, McNutt NS, Albino AP. Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Implications for tumor progression. Am J Pathol 1994;144:329-336
21. Fleming MG, Howe SF, Graf LH Jr. Expression of insulin-like growth factor I (IGF-I) in nevi and melanomas. Am J Dermatopathol 1994;16:383-391
22. Ciotti P, Pesce GP, Cafiero F, Rainero ML, Sementa A, Nicolo G, Mela GS, Bagnasco M, Santi PL, Bianchi-Scarra G. Intercellular adhesion molecule-1 (ICAM-I) and granulocyte-macrophage colony stimulating factor (GM-CSF) co-expression in cutaneous malignant melanoma lesions. Melanoma Res 1999;9:253-260
23. Duncan LM, Deeds J, Cronin FE, Donovan M, Sober AJ, Kauffman M, McCarthy JJ. Melastatin expression and prognosis in cutaneous malignant melanoma. J Clin Oncol 2001;19:568-576
24. Deeds J, Cronin F, Duncan LM. Patterns of melastatin mRNA expression in melanocytic tumors. Hum Pathol 2000;31:1346-1356
25. Amae S, Fuse N, Yasumoto K, Sato S, Yajima I, Yamamoto H, Udono T, Durlu YK, Tamai M, Takahashi K, Shibahara S. Identification of a novel isoform of microphthalmia-associated transcription factor that is enriched in retinal pigment epithelium. Biochem Biophys Res Commun 1998;247:710-715
26. Baxter LL, Pavan WJ. The oculocutaneous albinism type IV gene Matp is a new marker of pigment cell precursors during mouse embryonic development. Mech Dev 2002;116:209-212
27. Potterf SB, Mollaaghababa R, Hou L, Southard-Smith EM, Hornyak TJ, Arnheiter H, Pavan WJ. Analysis of SOX10 function in neural crest-derived melanocyte development: SOX10-dependent transcriptional control of dopachrome tautomerase. Dev Biol 2001;237:245-257
28. Surace EM, Angeletti B, Ballabio A, Marigo V. Expression pattern of the ocular albinism type 1 (Oa1) gene in the murine retinal pigment epithelium. Invest Ophthalmol Vis Sci 2000;41:4333-4337
29. Lister JA, Close J, Raible DW. Duplicate mitf genes in zebrafish: complementary expression and conservation of melanogenic potential. Dev Biol 2001;237:333-344
30. Jin EJ, Erickson CA, Takada S, Burrus LW. Wnt and BMP signaling govern lineage segregation of melanocytes in the avian embryo. Dev Biol 2001;233:22-37
31. Kumasaka M, Sato S, Yajima I, Yamamoto H. Isolation and developmental expression of tyrosinase family genes in xenopus laevis. Pigment Cell Res 2003;16:455-462
32. Stjernschantz J, Ocklind A, Wentzel P, Lake S, Hu DN. Latanoprost-induced increase of tyrosinase transcription in iridial melanocytes. Acta Ophthalmol Scand 2000;78:618-622
33. Takada K, Sugiyama K, Yamamoto I, Oba K, Takeuchi T. Presence of amelanotic melanocytes within the outer root sheath in senile white hair. J Invest Dermatol 1992;99:629-633
34. Suzuki I, Kato T, Motokawa T, Tomita Y, Nakamura E, Katagiri T. Increase of pro-opiomelanocortin mRNA prior to tyrosinase, tyrosinase-related protein 1, dopachrome tautomerase, Pmel-17/gp100, and P-protein mRNA in human skin after ultraviolet B irradiation. J Invest Dermatol 2002;118:73-78